Q3 2025 Management View CEO Joseph Payne reported that interim Phase II data for ARCT-032, the company’s mRNA therapeutic candidate for cystic fibrosis (CF), showed "treatment with inhaled ...
Falling wholesale ‘swap’ lending rates, which help determine the cost of fixed-rate mortgages, have given rise to another round of mortgage cuts this week, writes Laura Howard. However, in a close ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback